Clinical trial
Value of the Time-Weighted Average (TWA) of Mean Arterial Pressure (MAP) and Cerebral Oximetry (rSO₂) as Predictors of Postoperative Tissue Perfusion Impairment in Patients Undergoing Cardiac Surgery
NCT07510711 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Value of the Time-Weighted Average (TWA) of Mean Arterial Pressure (MAP) and Cerebral Oximetry (rSO₂) as Predictors of Postoperative Tissue Perfusion Impairment in Patients Undergoing Cardiac Surgery
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- November 30, 2027
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
delirium - postoperative, intensity care unit length of stay, postoperative acute kidney injury, postoperative cognitive dysfunction (pocd), postoperative morbidity